Long-acting semaglutide biosimilar(Inventage Lab)

N/A

Report date: 2025/03/07 17:53:09

Base Information

Drug NameLong-acting semaglutide biosimilar(Inventage Lab)
Drug Alias NameIVL-3021IVL3021
ClassificationBiologics > Protein drugs > Recombinant polypeptideBiologics > Biosimilar
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsObesityDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInventage Lab Inc
China Registration ClassN/A

Develop Information

Active CompaniesInventage Lab IncYuhan Corp
Inactive CompaniesN/A
Active IndicationsObesityDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A